Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools
In the past decade, significant progresses have taken place in the field of cancer immunotherapy. Tumor-targeting immunotherapies are being developed for most human cancers, including melanoma, prostate cancer, glioblastoma, sarcoma, lung carcinoma and hepatocellular carcinoma. The FDA has approved...
Salvato in:
| Autori principali: | , , |
|---|---|
| Natura: | Online |
| Lingua: | inglese |
| Pubblicazione: |
Frontiers Media SA
2021
|
| Soggetti: | |
| Accesso online: | 17750 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
Documenti analoghi: Cancer Immunotherapy & Immuno-monitoring: Mechanism, Treatment, Diagnosis, and Emerging Tools
- Tumor Cell/Dendritic Cell Interactions and the Influence of Tumors on Dendritic Cell-mediated Anti-Tumor Immune Responses and Dendritic Cell-Based Tumor Immunotherapies
- Journal for ImmunoTherapy of Cancer
- Immunotherapy for Tumor in the Brain: Insights From - and For - Other Tumor Sites
- Immune Checkpoint Molecules and Cancer Immunotherapy
- ImmunoMedicine
- Immunogenic Cell Death in Cancer: From Benchside Research to Bedside